APP and Alzheimer disease: This is based on the interaction of GSK-3 (and more precisely, its beta isoform, GSK-3β) with many of the cellular components related to the neuropathology of AD, such as the amyloid precursor protein, the Aβ peptide, the metabolic pathway leading to acetylcholine synthesis, which are mutated in many cases of familial AD.